Skip to content

Cognitive Behavioral Therapy (CBT) for Late Life Anxiety

Implementation of Cognitive-behavioral Therapy for Older Adults With Generalized Anxiety Disorder

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05380115
Enrollment
0
Registered
2022-05-18
Start date
2024-07-31
Completion date
2025-02-28
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder

Keywords

late-life anxiety, aging, cognitive-behavioral therapy

Brief summary

The purpose of this research study is to assess the acceptability and feasibility of the implementation strategy and fidelity of cognitive-behavioral therapy (CBT) for older adults with Generalized Anxiety Disorder.

Detailed description

All participants will receive CBT. Each subject will be given a workbook and each chapter in the workbook provides information about a different coping strategy for managing worry and anxiety. There will be a daily assignment in the workbook to complete before a call with the personal study coach. For 10 weeks, participants will have a 45-50 minute session (telephone or video) each week with their study coach. These calls will be confidential. The participant and the personal study coach will review the assigned chapter and completed homework during the weekly telephone sessions. Participants will also fill out questionnaires before starting sessions, when completing all 10 sessions, and 6 months after completing sessions.

Interventions

BEHAVIORALCognitive Behavioral Therapy (CBT)

weekly one on one video or telephone interviews with a study coach

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* participants who have had an outpatient visit to an Atrium provider * at least one of the following: any diagnosis of an anxiety or depressive disorder; anxiety, depression, or sleep disturbance as a symptom in the problem list or in the note; and use of anxiolytic, anti-depressant, and sleep aide medications.

Exclusion criteria

* diagnosis of dementia or cognitive impairment in the problem list

Design outcomes

Primary

MeasureTime frameDescription
Feasibility-Expectancy Rating ScaleWeek 1Assesses beliefs in how logical the treatment received seems, confidence in undergoing treatment/recommending to others, and expectations for success. Used in anxiety treatment studies with older adults. Scores can range from 4 to 40; higher scores indicate more positive expectations.
Generalized Anxiety Disorder scale (GAD-7)Week 11Self-report measure of GAD symptoms. Total scores can range from 0 to 21; higher scores indicate more GAD symptoms.
Penn State Worry Questionnaire-Abbreviated (PSWQ-A)week 118-item measure of frequency/intensity of worry; most commonly used worry measure. Scores can range from 8 to 40; higher scores indicate higher levels of worry.
Feasibility-Number of participants who complete at least 75% of sessionsWeek 11
Feasibility-Intervention adherenceWeek 11The percentage of completed sessions

Secondary

MeasureTime frameDescription
Generalized Anxiety Disorder scale (GAD-7)BaselineSelf-report measure of GAD symptoms. Total scores can range from 0 to 21; higher scores indicate more GAD symptoms.
Penn State Worry Questionnaire-Abbreviated (PSWQ-A)baseline8-item measure of frequency/intensity of worry; most commonly used worry measure. Scores can range from 8 to 40; higher scores indicate higher levels of worry.
Feasibility-Working Alliance Inventory, ClientWeek 11Assesses therapist-client working alliance. 12 items on a 7-point scale (1=never; 7=always); scores can range from 12 to 84 with higher scores indicating better working relationship.
Patient-Reported Outcomes Measurement Information System (PROMIS)baseline, week 6, week 118-item measure of general anxiety symptoms; each item is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always); scores can range from 8 to 40; higher scores indicate greater severity of anxiety.
Insomnia Sleep Indexbaseline, week 6, week 117-item self-report measure of type and severity of insomnia symptoms. A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem); scores can range from 0 to 28 with higher scores indicating more severe insomnia.
Feasibility-Client Satisfaction QuestionnaireWeek 11Assesses satisfaction with treatment. Scores can range from 8 to 32; higher scores indicate more satisfaction.
Feasibility-Working Alliance Inventory, TherapistWeek 11Assesses therapist-client working alliance. 12 items on a 7-point scale (1=never; 7=always); scores can range from 12 to 84 with higher scores indicating better working relationship.

Other

MeasureTime frameDescription
Healthcare Utilization-Number of Outpatient encountersWeek 37
Qualitative InterviewsWeek 11Analyses will be primarily conducted by Q-PRO
Healthcare Utilization-Costs for outpatient encounters, ED visits and inpatient staysWeek 37
Healthcare Utilization-Number of inpatient staysWeek 37
Healthcare Utilization-Number of ED visitsWeek 37

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026